Scribe Therapeutics, Inc 美股招股说明书 S-1（2026-07-02首版）（英文版）（297页）.pdf

1、S-1 1 d21355ds1.htm S-1Table of ContentsAs filed with the Securities and Exchange Commission on July 2,2026.Registration No.333-UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549FORM S-1REGISTRATION STATEMENTUnderThe Securities Act of 1933SCRIBE THERAPEUTICS INC.(Exact name of Regis

2、trant as specified in its charter)Delaware 2836 82-2157847(State or other jurisdiction ofincorporation or organization)(Primary Standard IndustrialClassification Code Number)(I.R.S.EmployerIdentification Number)1150 Marina Village ParkwayAlameda,California 94501(510)626-8587(Address,including zip co

3、de,and telephone number,including area code,of registrants principal executive offices)Benjamin L.Oakes,Ph.D.Chief Executive Officer1150 Marina Village ParkwayAlameda,California,94501(510)626-8587(Name,address,including zip code,and telephone number,including area code,of agent for service)Copies to

4、:Effie ToshavRobert A.FreedmanRyan MittenessFenwick&West LLP401 Union Street5th FloorSeattle,Washington 98101(206)389-4510 B.Shayne KennedyRoss McAloonLatham&Watkins LLP650 Town Center Drive20th FloorCosta Mesa,California 92626(714)540-1235Approximate date of commencement of proposed sale to the pub

5、lic:As soon as practicable after the effective date of this registration statement.If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following box.If this Form is filed to register

6、 additional securities for an offering pursuant to Rule 462(b)under the Securities Act,please check the following box and list the Securities Act registration statement number of the earliereffective registration statement for the same offering.If this Form is a post-effective amendment filed pursua